Actuate Therapeutics, Inc. Payments of Debt Issuance Costs
Actuate Therapeutics, Inc. (ACTU) reported Payments of Debt Issuance Costs of $34.63 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-14
- Actuate Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2026-06-30 was $34.63K, a 17.05% decline year-over-year.
- Actuate Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Actuate Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2025-06-30 was $41.75K.
- Actuate Therapeutics, Inc. payments of debt issuance costs for the quarter ending 2025-03-31 was $133.48K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month |
|---|---|---|
| 2026-06-30 | $34.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $34.63K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $41.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $175.23K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $133.48K 10-Q · filed 2026-05-14 | |
| 2024-06-30 | $185.73K 10-Q · filed 2024-09-24 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |